Bregs increase not only in primary tumor tissues [104] but also in the metastatic bone tissues of patients [105] and produce immunosuppressive molecules, such as TGFβ, IL10, and IL35, which promote tumor progression and metastasis directly and indirectly as described above [104,106]. Here, IL10 is linked to neoplasm.